Shots: Oncolytics collaborates with Merck KGaA and Pfizer to co-develop Oncolytics’ pelareorep in P-II BRACELET-1 study plus paclitaxel and avelumab. The cost of P-II trial will be shared b/w Pfizer […]readmore
Tags : Oncolytics Biotech